Dewey Steadman
Stock Analyst at Canaccord Genuity
(0.67)
# 3,911
Out of 4,944 analysts
34
Total ratings
41.67%
Success rate
-25.59%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dewey Steadman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Maintains: Buy | $75 → $70 | $88.74 | -21.12% | 5 | Nov 12, 2018 | |
| PCRX Pacira BioSciences | Maintains: Hold | $45 → $49 | $24.96 | +96.35% | 14 | Oct 2, 2018 | |
| AMRX Amneal Pharmaceuticals | Maintains: Hold | $18 → $21 | $9.40 | +123.40% | 1 | Aug 14, 2018 | |
| ACET Adicet Bio | Downgrades: Sell | n/a | $0.69 | - | 4 | Apr 19, 2018 | |
| LPCN Lipocine | Downgrades: Hold | n/a | $3.02 | - | 3 | Jan 11, 2018 | |
| SVRA Savara | Maintains: Buy | $18 → $25 | $2.70 | +825.93% | 2 | Oct 30, 2017 | |
| PRGO Perrigo Company | Maintains: Buy | $88 → $100 | $23.66 | +322.65% | 5 | Sep 13, 2017 |
ANI Pharmaceuticals
Nov 12, 2018
Maintains: Buy
Price Target: $75 → $70
Current: $88.74
Upside: -21.12%
Pacira BioSciences
Oct 2, 2018
Maintains: Hold
Price Target: $45 → $49
Current: $24.96
Upside: +96.35%
Amneal Pharmaceuticals
Aug 14, 2018
Maintains: Hold
Price Target: $18 → $21
Current: $9.40
Upside: +123.40%
Adicet Bio
Apr 19, 2018
Downgrades: Sell
Price Target: n/a
Current: $0.69
Upside: -
Lipocine
Jan 11, 2018
Downgrades: Hold
Price Target: n/a
Current: $3.02
Upside: -
Savara
Oct 30, 2017
Maintains: Buy
Price Target: $18 → $25
Current: $2.70
Upside: +825.93%
Perrigo Company
Sep 13, 2017
Maintains: Buy
Price Target: $88 → $100
Current: $23.66
Upside: +322.65%